<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02702921</url>
  </required_header>
  <id_info>
    <org_study_id>ESC-15-001</org_study_id>
    <nct_id>NCT02702921</nct_id>
  </id_info>
  <brief_title>Powered Vascular Stapler in Video-Assisted Thoracoscopic (VAT) Lobectomies</brief_title>
  <official_title>A Prospective, Randomized, Controlled, Multi-Center Evaluation of a Powered Vascular Stapler in VAT Lobectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized, controlled, multi-center study will collect and compare data
      from the surgeon's current Standard Of Care stapler (for Pulmonary Artery/Pulmonary Vein
      transection) and powered vascular stapler.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2016</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of hemostatic interventions/procedures completed due to bleeding at the staple line related to the transection of the vessel</measure>
    <time_frame>Intra-Operative</time_frame>
    <description>Incidence of hemostatic interventions/procedures defined as: additional stapling, over-sewing, clip placement, compression, use of suture, sealant, and/or buttress, use of energy, blood product transfusion or an additional surgical procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hemostatic interventions /procedures completed for post-operative bleeding related to the transection of the vessel</measure>
    <time_frame>From completion of procedure to 4 weeks post-operative (study completion)</time_frame>
    <description>Incidence of hemostatic interventions/procedures defined as: blood or blood product transfusion or an additional surgical procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">201</enrollment>
  <condition>Non Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Surgeon's 'standard of care' stapler</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgeon's current standard of care stapler</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ethicon Powered Vascular Stapler</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ethicon Powered Vascular Stapler</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgeon's 'standard of care' stapler</intervention_name>
    <arm_group_label>Surgeon's 'standard of care' stapler</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ethicon Powered Vascular Stapler</intervention_name>
    <arm_group_label>Ethicon Powered Vascular Stapler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with a confirmed or suspected diagnosis of stage IA to stage IIIA non-small
             cell lung cancer scheduled for a lobectomy (Lung Cancer Staging per American Joint
             Committee on Cancer,7th Edition)5;

          -  Subjects scheduled for VATS lobectomy in accordance with their institution's Standard
             Of Care;

          -  Performance status 0-1 (Eastern Cooperative Oncology Group classification);

          -  American Society of Anesthesiologists (ASA) score &lt;/= 3;

          -  No prior history of VAT or open lung surgery (on the lung in which the procedure will
             be performed);

          -  Willing to give consent and comply with study-related evaluation and treatment
             schedule; and

          -  At least 18 years of age.

        Exclusion Criteria

          -  Prior chemotherapy or radiation (within 30 days prior to the procedure or the duration
             of the subject's enrollment);

          -  Pregnancy;

          -  Physical or psychological condition which would impair study participation; or

          -  The subject is judged unsuitable for study participation by the Investigator for any
             other reason.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2016</study_first_posted>
  <last_update_submitted>May 30, 2017</last_update_submitted>
  <last_update_submitted_qc>May 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>March 29, 2018</submitted>
    <returned>April 30, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

